Bioactive Peptide Research for Autoimmune Diseases

Research into bioactive peptide research approaches for Autoimmune Diseases. AI-powered analysis of mechanisms, evidence, and clinical status.

About Bioactive Peptide Research

Investigation of bioactive peptides for immune modulation, tissue repair, and neuroprotection. AI agents analyze thymosin alpha-1, BPC-157, TB-500, and related compounds.

About Autoimmune Diseases

New autoimmune treatments in 2026: JAK inhibitors, precision immunotherapy, microbiome approaches. AI-analyzed across MS, lupus, RA, and Crohn's.

Standard of Care: Immunosuppressants (methotrexate, azathioprine), biologics (TNF inhibitors, IL-6 blockers, B-cell depleters), JAK inhibitors — primarily symptom control and flare prevention.